C-reactive protein as a predictor of improvement and readmission in heart failure. - Wikidata - wikimedia - TriplyDB

C-reactive protein as a predictor of improvement and readmission in heart failure.

C-reactive protein as a predictor of improvement and readmission in heart failure.

http://www.wikidata.org/entity/Q33147741

about

Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy.Collapse query cause: the management of adult syncope in the emergency department Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence.Salt intake is associated with inflammation in chronic heart failure.Oxidative stress markers and C-reactive protein are related to severity of heart failure in patients with dilated cardiomyopathy Low health-related quality of life is a predictor of major adverse cardiovascular events in patients with chronic nonischemic heart failure.Depression is the strongest predictor of long-term outcome in patients with chronic nonischemic heart failure Inhibition of Na+-H+ exchange by cariporide reduces inflammation and heart failure in rabbits with myocardial infarction.In patients with stable heart failure, soluble TNF-receptor 2 is associated with increased risk for depressive symptoms Prognostic impact of baseline high-sensitivity C-reactive protein in patients with acute myocardial infarction undergoing percutaneous coronary intervention based on body mass index Biomarkers of cardiac disease.Toxicological effect of TiO2 nanoparticle-induced myocarditis in mice.A meta-analysis of proinflammatory cytokines in chronic heart failure.Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis Ambient temperature and biomarkers of heart failure: a repeated measures analysis.The role of erythropoietin in myocardial protection: potential mechanisms and applications.Cardiovascular risk factor investigation: a pediatric issue.Evaluation and comparison of biomarkers in heart failure Neutrophil-to-lymphocyte ratio predicts response to cardiac resynchronization therapy.Readmission to a surgical intensive care unit: incidence, outcome and risk factors Physical and psychological symptom profiling and event-free survival in adults with moderate to advanced heart failure.Echocardiography, spirometry, and systemic acute-phase inflammatory proteins in smokers with COPD or CHF: an observational study C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study.New and emerging biomarkers of heart failure.Study of High Sensitive C-Reactive Protein (HS-CRP) After Cardiac Rehabilitation Program in Patients Undergoing Isolated CABG.A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease.Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome.Novel biomarkers for heart failure.'Lone' increase in C-reactive protein after cardiac surgery: prevalence, clinical characteristics, in-hospital course, and prognostic value.Prognostic Significance of Plasma High-Sensitivity C-Reactive Protein in Patients With Hypertrophic Cardiomyopathy.Combination stem cell therapy for heart failure.Trimetazidine shortens QTc interval in patients with ischemic heart failure.Trimetazidine: the future of cardiac function?Predictors of 30-day readmission in patients hospitalized with decompensated heart failure.Increased neutrophil lifespan in patients with congestive heart failure.Tetrahydrobiopterin corrects Escherichia coli endotoxin-induced endothelial dysfunction.C-reactive protein level on admission and time to and cause of death in patients hospitalized for acute heart failure.Novel Biomarkers for the Risk Stratification of Heart Failure with Preserved Ejection Fraction.

P2860

Q28219483-46E8BF3A-C090-461E-88C5-E4DF1D177E4B Q30497085-7B1EADC0-4C7E-4225-B647-BD94932CB4E8 Q33154072-54DCADAC-2E3D-4B30-BA7C-85C61775895E Q33699467-B1CE262A-0DA5-4FE3-9ECF-31B4C710A66C Q33862358-5EF7DCEF-86BF-4A55-AAA4-8EBEF373B24E Q33942433-22EAA7EE-F082-4AE7-AD8C-177A1CFAFF19 Q34481181-25884886-69F9-41AF-8713-6F393190E04A Q34821528-E7852459-F6B5-47E1-8688-A240CC602061 Q34821932-C2250FD3-598C-42DC-A1F2-F1394995E6B6 Q35047455-62E7AF48-3268-46CD-BF8E-4D4FF272EFFB Q35659594-4B40E174-026F-43C0-9085-3C431A03EB8D Q35866702-90C1C1B2-2997-481C-857A-44C1CA0A7132 Q35938537-6B425D04-74B9-4A97-8539-3BBE67C55CA3 Q35946850-E9C4D8F7-7280-4CCB-AF33-E1A9ED2122F9 Q36057476-A237D5A7-7C1F-457F-A499-CCA165114007 Q36204135-AB2EB777-FC78-4B60-89D5-B6C422BB8A1E Q36229049-BAAE656C-8E26-4CBC-86AD-B632CDE7FC3E Q36352011-5F157400-7F06-4EAD-A053-D709A9430CC4 Q36687298-98D3C6E1-64F8-47FF-8C35-8082760B1671 Q36776556-FA43E050-D5C2-4D2B-9D57-C1D38E53BD8A Q36873806-8EB456D8-D7FB-46EB-A198-4B7684899CC7 Q36993153-5F635DF4-AC44-4578-8C88-B075B80371F6 Q37146882-EDD3876D-319B-4780-841D-77DDA6923B39 Q37297427-9A503465-01F8-4FB0-98EE-866E6DBF5EDB Q37462413-201405D1-9BD2-4D9A-8BEF-EF81F7A41373 Q37514230-7F06426C-5206-4355-9C9D-71AF5F6A4F38 Q37608077-6D873185-FEBB-4947-A116-5395139BBFE1 Q37866294-D8217DC9-786A-439E-A251-5398F2FDC718 Q37891878-1047E236-BD87-445B-8333-CA2DE47FC8F5 Q38131790-B6C266F3-23D5-47A0-AA8A-6CF0AF73B594 Q40412887-70B0481B-A376-4371-9019-3D2DD65173C8 Q41102423-0E4725A0-1A32-41E9-A592-9FEAD5B20671 Q41194503-CF83323E-8820-45C2-9D0A-02DDE7816220 Q43228705-4193D948-6A39-4856-88E0-8F4520FD167D Q43284147-34C1F1E3-08EE-44AA-8A8D-86C98E6D22B1 Q44459406-E1F0D8C2-41CF-4F66-8F03-B136556D72EB Q46093168-4C208FE2-A164-4291-9424-3C5FDB6DAD45 Q46555003-71158A6C-22AC-4743-8592-1171A7EB2B1F Q47777713-9E9F3F89-9511-4FCD-B862-59240FF330E3 Q48156451-28D54C2F-B7F9-4A19-AF54-77A442C4C0FE

P2860

C-reactive protein as a predictor of improvement and readmission in heart failure.

http://www.wikidata.org/entity/Q33147741

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

name

C-reactive protein as a predictor of improvement and readmission in heart failure.

@ast

C-reactive protein as a predictor of improvement and readmission in heart failure.

@en

type

label

C-reactive protein as a predictor of improvement and readmission in heart failure.

@ast

C-reactive protein as a predictor of improvement and readmission in heart failure.

@en

prefLabel

C-reactive protein as a predictor of improvement and readmission in heart failure.

@ast

C-reactive protein as a predictor of improvement and readmission in heart failure.

@en

P1433

Q33147741-6BEDBB3D-AE02-45CF-B1C8-0F23D565B253

P1476

Q33147741-D63942A7-9053-4D17-8FDD-C17027B1B908

P2093

Q33147741-209CF78D-906D-4980-AB3A-ACE0381E9AF8

Q33147741-4FC02FDB-16DD-4200-8408-148A84DFCE13

Q33147741-7804E67D-9326-400E-9CF5-69DAA1948A3A

Q33147741-A09546D1-3D63-4DC9-A93E-85E0892AABC8

Q33147741-A8C74833-4D9E-477C-ACD4-ACA8CF528959

Q33147741-DEFC7E0C-2D26-4BA6-86AB-459A01B1D64C

P2860

Q33147741-04647FD1-BAF8-4B18-B06D-D6724C36983A

Q33147741-069EEA24-D177-4850-91FB-D0556075379D

Q33147741-1A26470B-F074-4D1B-9394-BC3008914DFD

Q33147741-33679B65-74AE-4E10-A37D-19A1F42C5C85

Q33147741-39E1909F-F9D2-4A93-830F-D411808CA259

Q33147741-3C05E730-6129-45CA-A3BD-5C063C906565

Q33147741-432B8988-F53C-45D6-8EFD-B5587F9D76F0

Q33147741-4EE60474-6BD2-4D58-90AB-BC9C8B0A732E

Q33147741-5B869D0E-FB83-4023-BF1F-186A52095976

Q33147741-697DF31B-2A93-4CF9-B4EB-4BDF6049A71C

P304

Q33147741-C68BC503-6F5F-4F3A-9A67-CDD8466B9396

P31

Q33147741-96EF7C14-3D02-453B-A97F-7C6C1390E21A

P356

Q33147741-82360445-1922-4A5A-A6D0-E6CC1C47493B

P433

Q33147741-28DD3BAB-6F67-4F06-B739-33A72557DBD3

P478

Q33147741-02DAEB07-0A67-4883-898F-3A119DF94974

P577

Q33147741-85839AB4-D377-43C3-B578-0466D99D2026

P698

Q33147741-3F3329E5-39B3-40B5-87F8-85526536D355

P921

Q33147741-6A6CEECE-33C9-44C5-9C66-AB564991D1A1

P356

S1388-9842(02)00021-1

P1433

European Journal of Heart Failure

P1476

C-reactive protein as a predictor of improvement and readmission in heart failure.

@en

P2093

Alonso-Martínez JL

http://www.w3.org/2001/XMLSchema#string

Echegaray-Agara M

http://www.w3.org/2001/XMLSchema#string

González-Arencibia C

http://www.w3.org/2001/XMLSchema#string

Llorente-Diez B

http://www.w3.org/2001/XMLSchema#string

Olaz-Preciado F

http://www.w3.org/2001/XMLSchema#string

Urbieta-Echezarreta M

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Nontraditional cardiovascular risk factors.

Evaluating novel cardiovascular risk factors: can we better predict heart attacks?

Risk factors for heart failure in the elderly: a prospective community-based study.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Studies of acute phase protein. I. An immunohistochemical method for the localization of Cx-reactive protein in rabbits. Association with necrosis in local inflammatory lesions.

Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1.

Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins)

Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group.

P304

331-336

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1388-9842(02)00021-1

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12034159

http://www.w3.org/2001/XMLSchema#string

P921